Hassan Fred has filed 27 insider transactions across 4 companies since June 2023.
Most recent transaction: a option exercise of 71839 shares of PRECIGEN, INC. ($PGEN) on March 13, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 13, 2026 | PRECIGEN, INC. | $PGEN | Hassan Fred | Director | M | Restricted Stock Units | 71839 | $0.00 | 0.0000 | 353,824,499 | 100.00% | 0.02% |
| March 13, 2026 | PRECIGEN, INC. | $PGEN | Hassan Fred | Director | M | Common Stock | 71839 | $0.00 | 1,243,239.0000 | 353,824,499 | 6.13% | 0.02% |
| March 10, 2026 | PRECIGEN, INC. | $PGEN | Hassan Fred | Director | A | Common Stock | 17948 | $3.51 | 1,171,400.0000 | 353,824,499 | 1.56% | 0.01% |
| March 10, 2026 | PRECIGEN, INC. | $PGEN | Hassan Fred | Director | A | Option to Purchase Common Stock (Right to Buy) | 41073 | $0.00 | 41,073.0000 | 353,824,499 | 9999.99% | 0.01% |
| March 10, 2026 | PRECIGEN, INC. | $PGEN | Hassan Fred | Director | A | Restricted Stock Units | 35612 | $0.00 | 35,612.0000 | 353,824,499 | 9999.99% | 0.01% |
| Jan. 9, 2026 | Cocrystal Pharma, Inc. | $COCP | Hassan Fred | Director | A | Stock Options (Right to Buy) | 16410 | $0.00 | 16,410.0000 | 13,784,065 | 9999.99% | 0.12% |
| Jan. 2, 2026 | EyePoint, Inc. | $EYPT | Hassan Fred | Not found | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 82,787,220 | 9999.99% | 0.05% |
| Oct. 28, 2025 | Cocrystal Pharma, Inc. | $COCP | Hassan Fred | Director | A | Warrants | 719426 | $1.39 | 719,426.0000 | 10,173,790 | 9999.99% | 7.07% |
| Oct. 28, 2025 | Cocrystal Pharma, Inc. | $COCP | Hassan Fred | Director | A | Common Stock | 359713 | $1.39 | 1,383,009.0000 | 10,173,790 | 35.15% | 3.54% |
| June 20, 2025 | BridgeBio Pharma, Inc. | $BBIO | Hassan Fred | Not found | A | Stock Option (Right to Buy) | 8425 | $0.00 | 8,425.0000 | 190,188,626 | 9999.99% | 0.00% |
| June 20, 2025 | BridgeBio Pharma, Inc. | $BBIO | Hassan Fred | Not found | A | Common Stock | 6589 | $0.00 | 25,889.0000 | 190,188,626 | 34.14% | 0.00% |
| March 14, 2025 | PRECIGEN, INC. | $PGEN | Hassan Fred | Director | M | Restricted Stock Units | 87412 | $0.00 | 0.0000 | 294,042,973 | 100.00% | 0.03% |
| March 13, 2025 | PRECIGEN, INC. | $PGEN | Hassan Fred | Director | A | Restricted Stock Units | 71839 | $0.00 | 71,839.0000 | 294,042,973 | 9999.99% | 0.02% |
| March 14, 2025 | PRECIGEN, INC. | $PGEN | Hassan Fred | Director | M | Common Stock | 87412 | $0.00 | 1,153,452.0000 | 294,042,973 | 8.20% | 0.03% |
| March 13, 2025 | PRECIGEN, INC. | $PGEN | Hassan Fred | Director | A | Common Stock | 36206 | $1.74 | 1,066,040.0000 | 294,042,973 | 3.52% | 0.01% |
| March 13, 2025 | PRECIGEN, INC. | $PGEN | Hassan Fred | Director | A | Option to Purchase Common Stock (Right to Buy) | 83517 | $0.00 | 83,517.0000 | 294,042,973 | 9999.99% | 0.03% |
| Jan. 3, 2025 | EyePoint, Inc. | $EYPT | Hassan Fred | Not found | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 9, 2024 | Cocrystal Pharma, Inc. | $COCP | Hassan Fred | Director | A | Common Stock | 8067 | $0.00 | 1,023,296.0000 | 0 | 0.79% | 0.00% |
| Sept. 3, 2024 | EyePoint, Inc. | $EYPT | Hassan Fred | Not found | A | Stock Options (Right to buy) | 60000 | $0.00 | 60,000.0000 | 0 | 9999.99% | 0.00% |
| June 21, 2024 | BridgeBio Pharma, Inc. | $BBIO | Hassan Fred | Not found | A | Stock Option (Right to Buy) | 26014 | $0.00 | 26,014.0000 | 0 | 9999.99% | 0.00% |
| March 14, 2024 | PRECIGEN, INC. | $PGEN | Hassan Fred | Director | A | Option to Purchase Common Stock (Right to Buy) | 101626 | $0.00 | 101,626.0000 | 0 | 9999.99% | 0.00% |
| March 14, 2024 | PRECIGEN, INC. | $PGEN | Hassan Fred | Director | A | Restricted Stock Units | 87412 | $0.00 | 87,412.0000 | 0 | 9999.99% | 0.00% |
| March 14, 2024 | PRECIGEN, INC. | $PGEN | Hassan Fred | Director | A | Common Stock | 44055 | $1.43 | 1,029,834.0000 | 0 | 4.47% | 0.00% |
| March 9, 2024 | PRECIGEN, INC. | $PGEN | Hassan Fred | Director | M | Restricted Stock Units | 106837 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 9, 2024 | PRECIGEN, INC. | $PGEN | Hassan Fred | Director | M | Common Stock | 106837 | $0.00 | 985,779.0000 | 0 | 12.16% | 0.00% |
| July 18, 2023 | Cocrystal Pharma, Inc. | $COCP | Hassan Fred | Director | A | Stock Options (Right to Buy) | 7333 | $0.00 | 7,333.0000 | 0 | 9999.99% | 0.00% |
| June 21, 2023 | BridgeBio Pharma, Inc. | $BBIO | Hassan Fred | Director | A | Stock Option (right to buy) | 51501 | $0.00 | 51,501.0000 | 0 | 9999.99% | 0.00% |